CME Group: Should Investors Chase Momentum Or Wait For A Dip?

Despite CME Group's 40% surge over the past year and recent all-time high, the stock still presents a buying opportunity due to its strong cash flow, market position, and dividend yield, with potential upside of approximately 20% based on discounted cash flow analysis. The company's record revenue of $1.64B and net income near $1B last quarter, driven by growth across various sectors, coupled with a 3.7% dividend yield, outweigh concerns about its rich valuation (29x trailing earnings) and potential risks such as regulatory changes, technology migration costs, and legal challenges.

Analysis

CME Group Inc. (CME) has demonstrated significant stock appreciation, rising 40% over the past year and recently achieving an all-time high of $290. Despite a valuation perceived as rich, with a trailing P/E of 29x, forward P/E of 27x, EV/EBITDA around 24x, and EV/Sales near 17x—premium metrics compared to peers like ICE, Nasdaq, and CBOE—the company's fundamental strengths appear to justify these levels. CME benefits from a robust "tollbooth" business model, generating substantial cash flow, particularly in volatile market conditions, and maintaining a strong market position with high net margins (over 57%) and EBIT margins (65%). The latest quarter saw record revenue of $1.64 billion and net income approaching $1 billion, with growth diversified across interest rates, equities, agricultural commodities, and energy. Management highlighted recurring market data revenue as a key growth driver and acknowledged challenges, including costs associated with migrating to Google Cloud and an upcoming legal trial in July. A discounted cash flow analysis, assuming an 8% discount rate, 4% terminal growth, and 11% TTM revenue growth, suggests a fair value around $350 per share, indicating approximately 20-21% upside. Positive news flow includes new crypto product launches, a $3 billion cash infusion from the OSTTRA stake sale, and a 36% year-over-year increase in April's average daily volume, complemented by a dividend yield exceeding 3.7%. Key risks include potential regulatory changes from bodies like the CFTC, such as a futures transaction tax or alterations to tax treatments, execution risks and costs associated with the Google Cloud migration, the outcome of the July class action lawsuit, and sensitivity to market volatility and interest rate changes affecting collateral income.

Key Decisions for Investors

• Investors could consider initiating or adding to positions in CME, particularly in the $270-$290 range, targeting a potential upside towards the $350 fair value estimate, viewing the current valuation as reflective of a high-quality, defensive, cash-generative business with a strong market moat.
• Monitor key developments closely, including regulatory pronouncements impacting the futures industry, progress and costs associated with the Google Cloud migration, and the outcome of the class action trial scheduled for July, as these could materially affect the stock's trajectory.
• Acknowledge the stock's sensitivity to market volatility and interest rate fluctuations; while high volatility generally benefits CME, a sustained quiet market or a significant drop in interest rates could impact earnings from trading volumes and collateral management, respectively.